With 84% of its sales coming from overseas and a 50% global market share in its flagship blood pressure monitors, OMRON Healthcare operates one of the most dynamic international supply chains in the healthcare industry. “As our international business expanded and new online channels emerged alongside traditional retail, our operations became increasingly complex,” recalls Kosuke Izawa, Senior General Manager of the Corporate Transformation HQ at OMRON Healthcare. “We recognized the need for headquarters to gain a clear view of global operations and manage them centrally.”
In 2018, OMRON Healthcare transitioned from regionally managed inventories to a centralized, headquarters-led model, consolidating both component and finished goods inventory across all global sites. When the COVID-19 pandemic struck, the company faced challenges such as semiconductor shortages, logistics disruptions, factory lockdowns, and extended lead times, all while global health awareness drove demand for blood pressure monitors and thermometers to unprecedented levels.
“Because we had already implemented centralized inventory management, we were able to allocate products where they were most needed,” says Kosuke Izawa. “Without Anaplan’s ability to drive globally optimized operations, we could not have effectively allocated limited products worldwide, and our business would have faced far greater disruption during the pandemic.”
Despite worldwide supply chain turmoil, OMRON Healthcare achieved record profits in 2020, reaching a milestone in the company’s transformation journey.